to cut down the chance of major cardiovascular events which include coronary heart assault, stroke, or death in adults with sort 2 diabetic issues with identified cardiovascular disease. Lilly stated any merchandise promoted as tirzepatide and never Mounjaro or Zepbound were not produced by the drugmaker and therefore are not approved with the U.